0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint | 
Michelle Huckaby Lewis, MD, JD
JAMA Pediatr. 2014;168(3):199-200. doi:10.1001/jamapediatrics.2013.4980.

Viewpoint | 
Prashant Mahajan, MD, MPH, MBA; Octavio Ramilo, MD; Nathan Kuppermann, MD, MPH
JAMA Pediatr. 2013;167(10):888-898. doi:10.1001/jamapediatrics.2013.2491.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Original Investigation  | 
Association of a Novel ACTA1 Mutation With a Dominant Progressive Scapuloperoneal Myopathy in an Extended Family
Kristen Zukosky, PhD; Katherine Meilleur, PhD; Bryan J. Traynor, MD, PhD; et al.
JAMA
Viewpoint  | 
The Precision Medicine Initiative:  A New National Effort
Euan A. Ashley, MRCP, DPhil
JAMA Oncology
Invited Commentary  | 
The Dual Role of Tumor-Infiltrating Lymphocytes in HER2-Positive Primary Breast Cancer:  Two Sides of the Same Coin?
Sibylle Loibl, MD, PhD
JAMA Oncology
Original Investigation  | 
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab:  A Secondary Analysis of the NeoALTTO Trial
Roberto Salgado, MD, PhD; Carsten Denkert, MD, PhD; Christine Campbell, MSc; et al.